TrialBMJ open2021

Cost-effectiveness of rapid laboratory-based mass-spectrometry diagnosis of bloodstream infection: evidence from the RAPIDO randomised controlled trial.

Padraig Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.